JPWO2023114320A5 - - Google Patents
Info
- Publication number
- JPWO2023114320A5 JPWO2023114320A5 JP2024533214A JP2024533214A JPWO2023114320A5 JP WO2023114320 A5 JPWO2023114320 A5 JP WO2023114320A5 JP 2024533214 A JP2024533214 A JP 2024533214A JP 2024533214 A JP2024533214 A JP 2024533214A JP WO2023114320 A5 JPWO2023114320 A5 JP WO2023114320A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- solvate
- disorders
- acceptable salt
- haloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163290037P | 2021-12-15 | 2021-12-15 | |
| US63/290,037 | 2021-12-15 | ||
| US202263387225P | 2022-12-13 | 2022-12-13 | |
| US63/387,225 | 2022-12-13 | ||
| PCT/US2022/052879 WO2023114320A1 (en) | 2021-12-15 | 2022-12-14 | Fused pyrrolidine psychoplastogens and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025502614A JP2025502614A (ja) | 2025-01-28 |
| JP2025502614A5 JP2025502614A5 (https=) | 2025-12-22 |
| JPWO2023114320A5 true JPWO2023114320A5 (https=) | 2025-12-22 |
Family
ID=86773439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024533214A Pending JP2025502614A (ja) | 2021-12-15 | 2022-12-14 | 縮合ピロリジンサイコプラストゲンとその使用 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4448532A4 (https=) |
| JP (1) | JP2025502614A (https=) |
| KR (1) | KR20240150418A (https=) |
| AU (1) | AU2022415426A1 (https=) |
| CA (1) | CA3239571A1 (https=) |
| IL (1) | IL313457A (https=) |
| MX (1) | MX2024007220A (https=) |
| TW (1) | TW202333736A (https=) |
| WO (1) | WO2023114320A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112023025599A2 (pt) | 2021-06-08 | 2024-02-20 | Entheogenix Biosciences Inc | Ativadores de dimetoxifenilalquilamina de receptores de serotonina. |
| TW202333668A (zh) | 2021-12-15 | 2023-09-01 | 美商德利克斯醫療公司 | 經苯氧基及苄氧基取代之精神成形素(psychoplastogen)及其用途 |
| EP4457203A4 (en) | 2021-12-27 | 2025-12-17 | Atai Therapeutics Inc | AMINOTETRALINE ACTIVATORS OF SEROTONIN RECEPTORS |
| EP4704822A1 (en) | 2023-05-01 | 2026-03-11 | ATAI Therapeutics, Inc. | Compositions and methods for treatment of diseases and disorders |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RO115522B1 (ro) * | 1995-02-02 | 2000-03-30 | Smithkline Beecham P.L.C. | Derivaţi de indolină, procedee pentru prepararea acestora, compoziţii farmaceutice care îi conţin şi metodă de tratament |
| PE20010052A1 (es) * | 1999-04-23 | 2001-01-27 | Upjohn Co | Compuestos de azepinindol tetraciclico como agonistas o antagonistas del receptor de 5-ht |
| AU2001292898A1 (en) * | 2000-09-20 | 2002-04-02 | Brad A. Acker | Substituted azepino[4,5b)indole derivatives |
| EP1632491A1 (en) * | 2004-08-30 | 2006-03-08 | Laboratorios Del Dr. Esteve, S.A. | Substituted indole compounds and their use as 5-HT6 receptor modulators |
| US20230295106A1 (en) * | 2019-10-14 | 2023-09-21 | The Regents Of The University Of California | Ergoline-like compounds for promoting neural plasticity |
-
2022
- 2022-12-14 CA CA3239571A patent/CA3239571A1/en active Pending
- 2022-12-14 AU AU2022415426A patent/AU2022415426A1/en active Pending
- 2022-12-14 KR KR1020247023489A patent/KR20240150418A/ko active Pending
- 2022-12-14 MX MX2024007220A patent/MX2024007220A/es unknown
- 2022-12-14 IL IL313457A patent/IL313457A/en unknown
- 2022-12-14 TW TW111148111A patent/TW202333736A/zh unknown
- 2022-12-14 JP JP2024533214A patent/JP2025502614A/ja active Pending
- 2022-12-14 EP EP22908391.0A patent/EP4448532A4/en active Pending
- 2022-12-14 WO PCT/US2022/052879 patent/WO2023114320A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106715417B (zh) | 药物中使用的吲哚衍生物 | |
| CN1133627C (zh) | N-苄基二氧代噻唑烷基苯甲酰胺衍生物的制造中间体及其制造方法 | |
| RU2286988C2 (ru) | Производные 4,5-дигидро-1h-пиразола, обладающие сильной cb1-антагонистической активностью | |
| CN1105708C (zh) | 1－苯基吡唑化合物类及其药学应用 | |
| RU95113149A (ru) | Трициклические производные пиразола | |
| JP2017524005A5 (https=) | ||
| JP2009513703A5 (https=) | ||
| JPH07501313A (ja) | キノロン誘導体 | |
| JP2007502295A5 (https=) | ||
| JP2006507220A5 (https=) | ||
| JP2594855B2 (ja) | 新規な３−シクロアルキルプロパンアミド、それらの互変異性形及び塩類、それらの製造法、薬剤としての使用並びにそれらを含有する組成物 | |
| JP2000504039A (ja) | アミノチアゾール誘導体、その製造方法およびそれを含有してなる医薬組成物 | |
| JP2018531230A (ja) | 医薬化合物 | |
| JP2018531230A6 (ja) | 医薬化合物 | |
| JP4377454B2 (ja) | Ｎｋ３拮抗物質としてのキノリン誘導体の塩 | |
| CN1255124A (zh) | 取代的异喹啉类衍生物以及它们作为抗惊厥剂的应用 | |
| JP7338711B2 (ja) | Ｄｐアンタゴニスト | |
| JP2004536853A5 (https=) | ||
| JP2004524361A (ja) | Ｓｔａｔ６−モジュレーターとしてのテトラヒドロキノリン誘導体、それらの製造および使用 | |
| JPWO2023114320A5 (https=) | ||
| RU2004139041A (ru) | Применение гетероаренкарбоксамидов в качестве дофамин-d3 лигандов для лечения заболеваний центральной нервной системы | |
| JP2018522915A5 (https=) | ||
| JP2001506653A (ja) | Ｃｒｆレセプターと相互作用するイソキノリナミン及びフタルアジナミン誘導体 | |
| JP2008518917A (ja) | Ｃｎｓ薬剤としての置換インドリジンおよび誘導体 | |
| JP2005528367A5 (https=) |